Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
European Heart Journal|January 13, 2022
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysisRajiv Agarwal, Gerasimos Filippatos, Bertram Pitt, et al.
Circulation|November 17, 2020
Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 DiabetesGerasimos Filippatos, Stefan D Anker, Rajiv Agarwal, et al.
The New England Journal of Medicine|December 2, 2020
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 DiabetesGeorge L Bakris, Rajiv Agarwal, Stefan D Anker, et al.
Circulation|November 15, 2021
Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD TrialGerasimos Filippatos, Stefan D Anker, Rajiv Agarwal, et al.
JACC. Heart Failure|November 3, 2022
Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and DiabetesGerasimos Filippatos, Stefan D Anker, Bertram Pitt, et al.
Diabetes, Obesity & Metabolism|September 28, 2021
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: A subgroup analysis from the FIDELIO-DKD trialPeter Rossing, Rajiv Agarwal, Stefan D Anker, et al.
Hypertension (Dallas, Tex. : 1979)|October 17, 2022
Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 DiabetesLuis M Ruilope, Rajiv Agarwal, Stefan D Anker, et al.
Journal of the American Society of Nephrology : JASN|November 4, 2021
Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD TrialRajiv Agarwal, Amer Joseph, Stefan D Anker, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 22, 2022
Kidney outcomes with finerenone: an analysis from the FIGARO-DKD studyLuis M Ruilope, Bertram Pitt, Stefan D Anker, et al.
European Journal of Heart Failure|March 3, 2022
Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trialGerasimos Filippatos, Bertram Pitt, Rajiv Agarwal, et al.
Pageof 4